ALX Oncology Holdings Inc (ALXO)
1.35
0.00 (0.00%)
USD |
NASDAQ |
Nov 14, 10:59
ALX Oncology Holdings Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2020 | 3.651M |
| March 31, 2020 | 4.419M |
| Date | Value |
|---|---|
| December 31, 2019 | 4.796M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
3.651M
Minimum
Jun 2020
4.796M
Maximum
Dec 2019
4.289M
Average
4.419M
Median
Mar 2020
Revenue (TTM) Benchmarks
| Biomarin Pharmaceutical Inc | 2.753B |
| Neurocrine Biosciences Inc | 2.243B |
| Eton Pharmaceuticals Inc | 31.38M |
| Verve Therapeutics Inc | 24.40M |
| Immuneering Corp | -- |